The current leading method to assess the presence of viruses and other biological markers of disease is effective but large and expensive. It is prohibitively difficult for use in many situations, especially due to certain economic and geographic factors.
A new review looks at the challenges of testing for Clostridioides (Clostridium) difficile infection (CDI) and recommendations for newer diagnostic tests.
The Food and Drug Administration (FDA) announces it has authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood.
The Food and Drug Administration (FDA) has permitted marketing of the Synovasure Lateral Flow Test Kit as an aid for the detection of periprosthetic joint infection (infection around a joint replacement) in the synovial (lubricant) fluid of patients being evaluated for revision surgery, which is
The Food and Drug Administration (FDA) announces it has cleared for marketing two tests that can detect the presence of the bacteria Chlamydia trachomatis and Neisseria gonorrhoeae, which cause the sexually-transmitted infections, respectively, chlamydia and gonorrhea, through diagnostic testing
In a breakthrough that could lead to a simple and inexpensive test for Ebola virus disease, researchers have generated two antibodies to the deadly virus.
A Korea Advanced Institute of Science and Technology (KAIST) research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours.
The management of febrile illness (fever) in children has a substantial impact on National Health Services resources in the UK, predominantly due to diagnostic uncertainty resulting from a lack of accurate tests to distinguish between viral and bacterial illness, a new study reports.
Agencies Launch Taskforce to Facilitate Rapid Availability of Diagnostic Tests During Public Health Emergencies
Today, the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) announced the launch of the Tri-Agency Task Force for Emergency Diagnostics.
A handheld 'tricorder' that can test for biological contamination in real-time has been the dream of science fiction fans for decades. And UBC Okanagan engineers say the technology is closer to science fact than ever before.